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CLASS OF BIOMATERIALS FOR 
MEDICAL USE 
Recent advances in the stem cell biology, the biomaterials science, and the 
design of the tissue culture bioreactors, help us address the growing need to 
find replacements for lost and worn-out human tissues and organs in an en-
tirely new way. Biological equivalents of native tissues are grown in a labora-
tory using tissue engineering techniques and investigated for their functionality, 
both in vitro and in animal models. We briefly review the key principles for 
engineering these advanced, native-like biomaterials capable to take over the 
lost function of our tissues. We also provide an example of the state of the art 
approach to the tissue engineering. 
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The tissue engineering is an area of science and 
technology expected to improve our lives, by offering 
new treatment options for regenerative medicine [1]. 
By creating biological substitutes of native tissues, the 
tissue engineering could help us outlive a failure of 
any of our organs. The overall objective of the whole 
tissue engineering is to restore the lost tissue 
function. Engineered tissues of sufficiently high 
fidelity are also providing physiologically relevant, yet 
controllable models for the fundamental research - for 
example, to study native or reprogrammed stem cells 
in native-like three-dimensional contexts of the deve-
lopment or a disease, or to screen drugs using micro-
array platforms with engineered human tissues [2]. 
Overall, the clinical and scientific utility of the 
tissue engineering critically depends on our ability to 
predictably direct the cells to express the right pheno-
type in the right place and at the right time. We obser-
ve that the same factors that regulate the tissue deve-
lopment  in vivo (molecular, structural, physical) can 
be used to direct the cell fate and tissue assembly in 
vitro. Therefore, the tissue engineering is largely an 
effort to “imitate nature” as it tends to recapitulate the 
native environment during the tissue development 
and remodeling in response to an injury or a disease, 
and thereby mobilize the regenerative potential of the 
cells [3,4]. 
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A “biomimetic” approach has been developed 
along these lines, by utilizing the cells (the actual “tis-
sue engineers”), biomaterial scaffolds (structural tem-
plates for the tissue formation) and bioreactors (provi-
ding environmental control and signaling cascades to 
guide the tissue formation). The engineering of a hu-
man cardiac tissue patch will be used to illustrate the 
biological requirements and engineering approaches 
for human applications [5,6]. 
BIOMIMETIC APPROACH 
In a living organism, cells are surrounded by 
other cells and embedded in an extracellular matrix 
(ECM) that defines the architecture, signaling and bio-
mechanics of the cellular microenvironment. Cellular 
processes are mediated by molecular, structural and 
physical cues, and their spatial and temporal gra-
dients. Cells respond to and remodel their immediate 
microenvironment, via homotypic or heterotypic inter-
actions with neighboring cells, and with the tissue ma-
trix. It is obvious that the biological complexity of the 
native cell context is not mimicked in the laboratory 
with standard 2D culture conditions. This is a major 
limitation to experiments investigating cellular respon-
ses  in vitro since much of the complex interplay of 
mechanical and molecular factors present in vivo is 
absent [5]. 
Biomaterial scaffolds provide structural templa-
tes for the cell attachment and the tissue growth, 
whereas bioreactors provide the environmental con-
trol. Scaffolds and bioreactors also provide a multi-G. VUNJAK-NOVAKOVIĆ: ENGINEERED TISSUE GRAFTS…  CI&CEQ 14 (4) 211−214 (2008) 
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tude of regulatory signals such as cytokines (diffusing 
or immobilized) and physical factors (hydrodynamic 
shear, mechanical stretch, electrical gradients). Both 
in vivo (during the development and regeneration) 
and in vitro (for the tissue engineering), the cues pre-
sented to cells are the principal determinants of the 
phenotypic nature and the function of the resultant tis-
sues (Figure 1). The design of the tissue engineering 
systems is necessarily inspired by biology. The com-
plementary engineering principles help recapitulate 
the combinations of parameters in the native environ-
ments of a specific tissue or organ, in order to orches-
trate the conversion of "collections of cells" into spe-
cific tissue phenotypes [1]. 
Biomaterial scaffolds 
An important component to the cell microenvi-
ronment is the surrounding matrix, with its cascades 
of biochemical and physical cues. In a natural setting, 
cells are embedded in a matrix that is composed of 
collagens, other proteins, polysaccharides, and water, 
and has a structure that depends on the location and 
function of the tissue. For instance, cartilage has high 
proteoglycan content within a strong collagen net-
work, a matrix that gives this tissue its important me-
chanical properties to sustain natural loading. In con-
trast, tendon is highly anisotropic with respect to ECM 
orientation, making mechanical properties directiona-
lly dependent. ECM mechanics can play a role in the 
differentiation of stem cells and can be engineered 
into synthetic matrices for directed differentiation. Ad-
vances in material synthesis and processing have ope-
ned up a range of synthetic and natural materials for 
use in controlled microenvironments [1]. Materials 
with a range of molecular, structural and mechanical 
properties have been designed and utilized for inter-
actions with stem cells, in form of porous, fibrous and 
hydrogel scaffolds. Porous scaffolds provide macro-
scopic voids for the migration and infiltration of cells, 
whereas fibrous scaffolds may be fabricated on a size- 
-scale that mimics the native ECM and may be aligned 
to control cellular alignment. 
Bioreactors 
Bioreactors are generally defined as devices in 
which biological processes (such as cell expansion, 
differentiation or tissue formation on biomaterial scaf-
 
Figure 1. Biomimetic approach. In vivo, the cell function and the tissue assembly depend on the culture substrate, the environmental 
conditions, the supply of nutrients, oxygen and growth factors, and the acting physical factors. These same regulatory factors can be 
utilized in vitro to engineer functional tissues by an integrated use of isolated cells, biomaterial scaffolds and bioreactors. The cells 
carry out the process of the tissue formation, in response to regulatory signals. G. VUNJAK-NOVAKOVIĆ: ENGINEERED TISSUE GRAFTS…  CI&CEQ 14 (4) 211−214 (2008) 
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folds) occur under tightly controlled environmental 
conditions (such as the exchange of oxygen, nutrients 
and metabolites, the application of molecular and phy-
sical regulatory factors). Universal requirements of the 
bioreactor design include efficient and controllable cell 
seeding of 3D scaffolds (at a desired cell density, high 
yield, high kinetic rate, and spatial uniformity) and the 
improved mass transfer between the gas phase and 
the culture medium (to control the oxygen supply and 
pH), and between the scaffold and the culture me-
dium (to control the exchange of nutrients, oxygen 
and metabolites with the cells) [4]. Typically, a mass 
transfer in bioreactors occurs by a combination of dif-
fusion and convection, similar to the mass transport in 
a human body. 
A tissue engineering bioreactor should ideally 
be based on the good understanding of the native en-
vironment for the tissue of interest. Tissue-engineer-
ing bioreactors are designed to precisely regulate the 
cellular microenvironment, support cell viability and 
organization, and provide control of signaling. Biore-
actors are also designed to account for specific me-
chanisms of nutrient transfer and specific physical fac-
tors inherent in the native tissue. 
CASE STUDY: ENGINEERING A CARDIAC PATCH 
FOR HEART REPAIR 
To describe some of the practical strategies that 
we currently use to engineer functional grafts and ad-
dress the challenges we face in translating the tissue 
engineering into preclinical studies, we will use car-
diac tissue engineering as an example. A congestive 
heart failure, which remains a major health problem 
without effective therapeutic modalities, is driving the 
research into cell-based therapies for cardiac repair. 
Recently, we have utilized human stem cells to derive 
human cardiovascular cell populations. We have also 
shown that the use of properly designed scaffolding 
materials and bioreactors can modulate cell pheno-
types and promote functional cell coupling into a con-
tractile cardiac patch (Figure 2) [7,8]. 
 
Figure 2. Cardiac tissue engineering: translation to human cells and large animal studies. The flow chart shows feedbacks between the 
three major areas of investigation: derivation of cardiac populations of human cells, engineering cardiac patch for cell delivery, and 
animal studies of heart regeneration. In cell culture studies, cardiac cell populations are derived from human stem cells by application of 
cytokines and matured by physical stimulation. In tissue engineering studies, these cell populations are cultured on scaffolding materials 
(suc hydrogels, elastomers, native tissue matrix) in a bioreactor with biophysical signaling, to form a synchronously contractile patch. In 
animal studies, cells are implanted onto the infarct bed either using a hydrogel as a delivery platform or in form of the cultivated 
contractile patch. The most promising cell delivery systems are advanced into larger animal studies (sheep or pig) to test the 
electromechanical coupling in a relevant preclinical model. G. VUNJAK-NOVAKOVIĆ: ENGINEERED TISSUE GRAFTS…  CI&CEQ 14 (4) 211−214 (2008) 
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The three features of native myocardium: high 
density of myocytes and supporting cells, efficient oxy-
gen exchange between the cells and blood, and syn-
chronous contractions orchestrated by electrical sig-
nal propagation form a set of design requirements for 
engineering cardiac tissue [6]. 
Our laboratory has developed a “biomimetic“ ap-
proach to the cardiac tissue engineering that involves 
an integrated use of cells, biomaterial scaffolds and 
bioreactors to engineer compact, millimeters-thick, 
synchronously contracting cardiac tissue constructs. 
Two main design considerations are to provide: (1) con-
vective-diffusive oxygen transport (critical for cell sur-
vival and function) and (2) excitation-contraction coup-
ling (critical for cell differentiation and assembly) [6-8]. 
To mimic the capillary network, cells were cultu-
red on porous scaffolds with an array of channels per-
fused with the culture medium (to provide a separate 
compartment for the medium flow) and the medium 
was supplemented with an oxygen carrier (to mimic 
the role of hemoglobin). This approach tends to pro-
vide in vivo like mechanisms of the oxygen supply to 
cultured cells and can overcome both the inherent li-
mitations of a diffusion transport in conventional cul-
ture systems and the adverse effects of shear in per-
fused non-channeled tissue constructs. 
In native heart, mechanical stretch is induced by 
electrical signals and the orderly coupling between 
electrical pacing signals and macroscopic contrac-
tions is crucial for the development and function of 
native myocardium. Electrical signals designed to in-
duce synchronous construct contractions during culti-
vation resulted in the progressive development of con-
ductive and contractile properties. 
Our ongoing studies are directed towards ad-
vancing our fundamental understanding of the unique 
properties of human stem cells and their utilization to 
treat a cardiac disease. Specifically, we are trying to 
make progress in two directions: (1) maturation of hu-
man cardiac and vascular cell phenotypes by biophy-
sical stimulation during the culture and (2) the provi-
sion of suitable delivery platforms enabling a cell re-
tention and environmental conditioning in ischemic 
myocardium. This work is based on the premise that 
unlocking the regenerative potential of human embry-
onic stem cells requires a reconstruction of some of 
the keys as key aspects found in the dynamic envi-
ronments during the native development and regene-
ration. We expect that developmentally inspired phy-
sical signals can be utilized to mature the phenotype 
of human cardiac progenitors derived from embryonic 
stem cells. 
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